Impaired JAK2-induced activation of STAT3 in failing human myocytes

Molecular BioSystems

Volumn 8, Issue 9, 2012, Pages 2351-2359

  Cambi, Giulia Elisa ^a   Lucchese, Gianluca ^b   Djeokeng, Mah Mc Harol ^a   Modesti, Alessandra ^a   Fiaschi, Tania ^a   Faggian, Giuseppe ^b   Sani, Guido ^a   Modesti, Pietro Amedeo ^a,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS;

ALPHA CYANO (3,4 DIHYDROXY) N BENZYLCINNAMIDE; ALPHA-CYANO-(3,4-DIHYDROXY)-N-BENZYLCINNAMIDE; ANGIOTENSIN II; ENZYME INHIBITOR; INTERLEUKIN 6; JANUS KINASE 2; STAT3 PROTEIN; TYRPHOSTIN;

ARTICLE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HEART FAILURE; HUMAN; METABOLISM; MUSCLE CELL; PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANGIOTENSIN II; BLOTTING, WESTERN; CELLS, CULTURED; ENZYME INHIBITORS; HEART FAILURE; HUMANS; INTERLEUKIN-6; JANUS KINASE 2; MUSCLE CELLS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TYRPHOSTINS;

EID: 84864704976     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c2mb25120e     Document Type: Article

References (30)

1. K. Boengler A. Buechert Y. Heinen C. Roeskes D. Hilfiker-Kleiner G. Heusch R. Schulz Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice Circ. Res. 2008 102 131 135
2. E. K. Podewski D. Hilfiker-Kleiner A. Hilfiker H. Morawietz A. Lichtenberg K. C. Wollert H. Drexler Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy Circulation 2003 107 798 802
3. J. J. Jacoby A. Kalinowski M. G. Liu S. S. Zhang Q. Gao G. X. Chai L. Ji Y. Iwamoto E. Li M. Schneider K. S. Russell X. Y. Fu Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age Proc. Natl. Acad. Sci. U. S. A. 2003 100 12929 12934
4. D. Hilfiker-Kleiner A. Hilfiker M. Fuchs K. Kaminski A. Schaefer B. Schieffer A. Hillmer A. Schmiedl Z. Ding E. Podewski V. Poli M. D. Schneider R. Schulz J. K. Park K. C. Wollert H. Drexler Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury Circ. Res. 2004 95 187 195
5. M. Kurdi G. W. Booz JAK redux: a second look at the regulation and role of JAKs in the heart Am. J. Physiol. Heart Circ. Physiol. 2009 297 H1545 H1556
6. J. Pan K. Fukuda H. Kodama S. Makino T. Takahashi M. Sano S. Hori S. Ogawa Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart Circ. Res. 1997 81 611 617
7. Z. Wen Z. Zhong J. E. Darnell, Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation Cell 1995 82 241 250
8. A. Modesti I. Bertolozzi T. Gamberi M. Marchetta C. Lumachi M. Coppo F. Moroni T. Toscano G. Lucchese G. F. Gensini P. A. Modesti Hyperglycemia activates JAK2 signaling pathway in human failing myocytes via angiotensin II-mediated oxidative stress Diabetes 2005 54 394 401
9. P. A. Modesti G. G. Neri Serneri T. Gamberi M. Boddi M. Coppo G. Lucchese M. Chiavarelli G. Bottai F. Marino C. Tozzetti G. F. Gensini A. Modesti Impaired angiotensin II-extracellular signal-regulated kinase signaling in failing human ventricular myocytes J. Hypertens. 2008 26 2030 2039
10. T. Frahm H. Hauser M. Köster IFN-type-I-mediated signaling is regulated by modulation of STAT2 nuclear export J. Cell Sci. 2006 19 1092 1104
11. R. Gimeno C. K. Lee C. Schindler D. E. Levy Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes Mol. Cell. Biol. 2005 25 5456 5465
12. E. Mascareno M. El-Shafei N. Maulik M. Sato Y. Guo D. K. Das M. A. Siddiqui JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion Circulation 2001 104 325 329
13. X. Li S. Leung S. Qureshi J. E. Darnell, Jr. G. R. Stark Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha J. Biol. Chem. 1996 271 5790 5794
14. M. Snyder X. Y. Huang J. J. Zhang Identification of novel direct Stat3 target genes for control of growth and differentiation J. Biol. Chem. 2008 283 3791 3798
15. M. Silva A. Benito C. Sanz F. Prosper D. Ekhterae G. Nuñez J. L. Fernandez-Luna Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines J. Biol. Chem. 1999 274 22165 22169
16. G. G. Neri Serneri M. Boddi I. Cecioni S. Vanni M. Coppo M. L. Papa B. Bandinelli I. Bertolozzi G. Polidori T. Toscano M. Maccherini P. A. Modesti Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function Circ. Res. 2001 88 961 968
17. Y. Zou I. Komuro T. Yamazaki S. Kudoh R. Aikawa W. Zhu I. Shiojima Y. Hiroi K. Tobe T. Kadowaki Y. Yazaki Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts Circ. Res. 1998 82 337 345
18. A. R. Simon U. Rai B. L. Fanburg B. H. Cochran Activation of the JAK-STAT pathway by reactive oxygen species Am. J. Physiol. 1998 275 C1640 C1652
19. C. T. Tsai L. P. Lai K. T. Kuo J. J. Hwang C. S. Hsieh K. L. Hsu C. D. Tseng Y. Z. Tseng F. T. Chiang J. L. Lin Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling Circulation 2008 117 344 355
20. J. R. Privratsky L. E. Wold J. R. Sowers M. T. Quinn J. Ren AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase Hypertension 2003 42 206 212
21. F. Amiri S. Shaw X. Wang J. Tang J. L. Waller D. C. Eaton M. B. Marrero Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose Kidney Int. 2002 61 1605 1616
22. M. Kurdi G. W. Booz Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling J. Cardiovasc. Pharmacol. 2007 50 126 141
23. F. Fiordaliso A. Leri D. Cesselli F. Limana B. Safai B. Nadal-Ginard P. Anversa J. Kajstura Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death Diabetes 2001 50 2363 2375
24. A. Stephanou T. M. Scarabelli B. K. Brar Y. Nakanishi M. Matsumura R. A. Knight D. S. Latchman Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701 J. Biol. Chem. 2001 276 28340 28347
25. P. Kovarik M. Mangold K. Ramsauer H. Heidari R. Steinborn A. Zotter D. E. Levy M. Müller T. Decker Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression EMBO J. 2001 20 91 100
26. D. S. Aaronson C. M. Horvath A road map for those who don't know JAK-STAT Science 2002 296 1653 1655
27. E. Mascareno M. Dhar M. A. Siddiqui Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter. A cellular signal for hypertrophy in cardiac muscle Proc. Natl. Acad. Sci. U. S. A. 1998 95 5590 5594
28. D. Vergara P. Simeone D. Toraldo P. Del Boccio V. Vergaro S. Leporatti D. Pieragostino A. Tinelli S. De Domenico S. Alberti A. Urbani M. Salzet A. Santino M. Maffia Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells Mol. Biosyst. 2012 8 1078 1087
29. S. R. Steinhubl Why have antioxidants failed in clinical trials? Am. J. Cardiol. 2008 22 14D 19D
30. C. McGreevy D. Williams New insights about vitamin D and cardiovascular disease: a narrative review Ann. Intern. Med. 2011 20 820 826